MAIA Biotechnology, Inc. (MAIA) Stock Ticker
Market factors today
Unlock the full MAIA picture
About MAIA Biotechnology, Inc.
MAIA Biotechnology, Inc. is a clinical-stage biotech firm dedicated to discovering, developing, and commercializing treatments for various cancers, with a primary focus on non-small cell lung cancer. The company's leading experimental compound, THIO, is an investigational drug candidate that utilizes a unique dual mechanism by targeting telomeres and stimulating an immune response. Established in 2018, the enterprise maintains its headquarters in Chicago, Illinois.
MAIA stock facts
| Ticker symbol | MAIA |
| Exchange | New York Stock Exchange Arca |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $73.0M |
| CEO | Vlad Vitoc |
| Employees | 13 |
| Headquarters | Chicago, IL, US |
| IPO date | 2022-07-28 |
| Website | www.MAIABiotech.com |
What you can see for MAIA on Tickr
Live MAIA price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the MAIA report.
Rankings
FAQ
What is the ticker symbol for MAIA Biotechnology, Inc.?
The ticker symbol for MAIA Biotechnology, Inc. is MAIA, listed on the New York Stock Exchange Arca.
What is MAIA?
MAIA Biotechnology, Inc. is a clinical-stage biotech firm dedicated to discovering, developing, and commercializing treatments for various cancers, with a primary focus on non-small cell lung cancer. The company's leading experimental compound, THIO, is an investigational drug candidate that utilizes a unique dual mechanism by targeting telomeres and stimulating an immune response. Established…